Abstract
Evidence of long-term beneficial effects of ß-blockers on mortality and morbidity in patients with heart failure has been demonstrated in recent randomized trials. However, not all ß-blockers are identical. Carvedilol, a nonselective ß- and a-adrenergic blocker, can potentially blunt the release of noradrenaline by blocking presynaptic ß2-adrenergic receptors. To test this hypothesis, we have compared the effects of carvedilol and atenolol on plasma noradrenaline during exercise in healthy young volunteers.
| Original language | English |
|---|---|
| Pages (from-to) | 134-138 |
| Number of pages | 5 |
| Journal | British Journal of Clinical Pharmacology |
| Volume | 55 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 2003 |
Fingerprint
Dive into the research topics of 'Differential effects of carvedilol and atenolol on plasma noradrenaline during exercise in humans'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver